Indefinite Delivery Contract W81K0018D0010

Award Date 10/1/18
Last Date to Order 9/30/23
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Roche Diagnostics Corporation has been awarded a blanket purchase agreement as a single-award indefinite-delivery contract vehicle by the Department of the Army Medical Command to provide cell staining supplies. Task orders issued against the agreement by the Defense Health Agency include diagnostic supplies valued at approximately $20,691, biopsy reagents valued at $13,763.54, and test kits valued at $14,181.97. All task orders were firm-fixed-price and included no set-aside designations,...
The Department of the Army Medical Command awarded Roche Diagnostics Corporation a single award blanket purchase agreement with a potential value of $140,000 to provide laboratory supplies and equipment. No set-aside provisions were specified in the award made on September 27, 2023. Roche Diagnostics Corporation was issued a $39,235 firm fixed price call against this agreement on September 27, 2023 to supply diagnostic testing materials to the Army medical treatment facility located at Fort...
The Department of the Army Medical Command awarded a single-award Blanket Purchase Agreement to Roche Diagnostics Corporation on July 22, 2022. The potential value of the BPA is $625,000 for the procurement of reagents and supplies with an ordering period through July 21, 2023. Roche Diagnostics Corporation will provide reagents and supplies to support the Department of the Army Medical Command's medical operations under the BPA. As the prime contractor, Roche will supply products to various...
Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of the Army Medical Command on August 30, 2011, with a potential value of $1,000,000. The contract provides for the delivery of a 454 GS Junior Genome Sequencer to support the agency's genomics research and analysis activities. Two delivery orders have been placed against the contract to date. The first, awarded on September 1, 2011 and valued at $17,923, scheduled delivery of the sequencing...
This federal contract IDV award was issued by the U.S. Army Medical Command (MEDCOM), a defense agency, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The single-award Indefinite Delivery Contract has a ceiling value of $10.9M and a period of performance through September 30, 2028. The contract provides for the delivery of clinical chemistry analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to VA hospitals, military treatment...
The Department of Veterans Affairs Veterans Health Administration has awarded Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a single-award indefinite delivery contract (IDC) to provide Roche brand reagents and consumables. The $100,685.04 firm fixed price delivery order has a period of performance through February 2027 and does not utilize any set-asides. Roche Diagnostics Corp, a foreign-owned for-profit manufacturer, is an established federal contractor that has...
Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The contract has a potential value of $1,115,564.58 to provide reagents and supplies with no set-aside designation. Performance will take place through January 31, 2028. Under this contract, Roche Diagnostics was issued a $210,121.69 firm fixed price delivery order for reagents and supplies. The delivery...
This indefinite delivery contract was awarded by the Defense Health Agency, a component of the Department of Defense, to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at up to $7,419,293.98, is for the provision of chemistry reagents to support medical research, disease detection, and patient care across various medical disciplines for the...
Roche Diagnostics Corporation has been awarded a blanket purchase agreement (BPA) by the Defense Health Agency to provide various medical diagnostic products and services. The BPA utilizes firm fixed price calls issued against it to procure items such as COBAS assays, laboratory equipment and supplies, and cardiopulmonary resuscitation testing. These products and services support the Agency's global network of medical facilities and aid in diagnostic testing, medical research, and healthcare...
Roche Diagnostics Corporation has been awarded a single-award blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to provide chemistry and immunochemistry cost per reportable result services. The agreement was awarded on December 18, 2020 under the Critical Analyzers, Laboratory Federal Supply Schedule contract vehicle, with a potential value of $7,495,585.90 to be delivered in Aurora, Colorado through January...
  • W81K0018D0010
    Indefinite Delivery Contract
  • 6
    Federal Contract Awards

Roche Diagnostics Corporation has been awarded an indefinite delivery contract by the Department of the Army Medical Command to provide immunochemistry testing services. The single award contract has a potential value of $16.6M and period of performance through September 2023.

Under the contract vehicle, Roche has received multiple delivery orders to conduct clinical chemistry and immunoassay testing at its facility in Castleton, Indiana for various Army medical treatment facilities. Orders have supported services at Brooke Army Medical Center in San Antonio, Texas valued at $1.7M to $2.9M with periods of performance from October 2019 to September 2021. Additional orders valued $1.6M to $2M were placed to support requirements at unspecified Army locations through September 2023.

All orders awarded to date have been firm fixed price, included no set aside designations, and involved Roche performing the diagnostic testing services from its Indiana location. The original solicitation sought immunochemistry testing capabilities to support the Department of the Army Medical Command's patient care and medical research programs. Roche's experience providing similar diagnostic solutions to other military and Department of Veterans Affairs medical facilities positions it well to deliver the specialized testing services required under this contract vehicle.

Generated 3/2/24, 9:06 AM